Delivery Order SPE2DB24D2205-SPE2DB25FEDYE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $53,908.10 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count units) on August 6, 2025, with an ultimate completion date of August 7, 2025. This firm fixed-price delivery order represents a non-set-aside, competitively awarded contract for pharmaceutical supply to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $65,345.95 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, awarded on August 28, 2025, with an ultimate completion date of August 29, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $13,297.03 to AmerisourceBergen Drug Corp for supply of Biktarvy 50-200-25 mg tablets (30-count units) with an ultimate completion date of August 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $4,718.58 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units) on September 4, 2025, with completion scheduled for September 5, 2025. This competitive award, issued without set-aside designation, reflects a firm fixed-price delivery order structure under the company's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $1,548.16 to AmerisourceBergen Drug Corp for Biktarvy 50-200-25 mg tablets (30-count unit dose packaging). The contract, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order is not set-aside and was competitively awarded. AmerisourceBergen, headquartered...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $126,226.42 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-unit packages). This is a firm fixed-price delivery order with an ultimate completion date of September 23, 2025, and was competitively awarded without a set-aside designation. The award was issued on September 22, 2025, to the vendor's corporate office located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $10,018.39 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of August 13, 2025, issued on August 12, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $34.5K delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Biktarvy 50-200-25 mg tablets in 30-unit packages. This non-set-aside, firm fixed-price contract represents a delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will fulfill this...
- The Defense Logistics Agency awarded a delivery order valued at $86,231.50 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. This firm fixed price delivery order, issued on July 24, 2025, with completion scheduled for July 25, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor within the federal...
- The Defense Logistics Agency awarded a $42,594.51 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Biktarvy 50-200-25 mg tablets in 30-count units. The delivery order, which is expected to be completed by July 29, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEDYEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at approximately $75,900 to AmerisourceBergen Drug Corp for the supply of Biktarvy 50-200-25 mg tablets (30-count units). The contract is a firm fixed-price delivery order with no set-aside designation, issued on June 20, 2025, with an ultimate completion date of June 23, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award reflects AmerisourceBergen's established capability to meet federal procurement requirements through competitive contracting, as the company maintains an extensive portfolio of medical product deliveries across multiple therapeutic domains for the Defense Logistics Agency and related government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $75.9k | 6/20/25 |